Baxter International (BAX) 10-Q2023 Q1 Quarterly report

Filed: 27 Apr 23, 7:20am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: addressed, arrived, banking, BPS, broader, CID, consummated, contractor, core, customary, cyclical, dense, distributor, ensure, EURIBOR, Fitch, foreseeable, high, identical, independent, innovation, intention, issuer, long, OAI, official, orderly, procurement, publicly, pursuit, recession, rental, responding, revised, simplified, simplify, spinoff, susceptible, tender, timeframe, watch

Removed: acknowledged, acquire, added, admitting, agreed, al, appointed, approval, Argentina, assembled, assumption, ASU, average, avoid, avoiding, award, Back, bariatric, base, beginning, Build, Caelyx, Canada, cancelling, Celerity, Cheetah, chronically, classify, competitor, concentrated, confirmatory, contingency, cooperated, cooperation, deductible, denying, depend, desire, desist, developed, disclose, discovery, divest, Doxil, enterprise, Erosion, Ethan, extinguishment, failing, female, file, final, Finalization, finalized, formed, frozen, gave, generating, globe, group, hesitancy, ill, impacting, improved, increasing, index, individual, infrastructure, Insurance, labeling, lessor, liquidation, LLC, Louisiana, making, mandatory, maternal, misleading, municipal, Mutual, nosocomial, obligated, obtain, Omicron, oncolytic, OUS, outbound, ownership, pace, pay, peak, pelvic, penalty, PerClot, Pfizer, PN, pneumonia, Police, preceding, preclude, preliminary, premix, profit, profitable, promulgated, purpose, putative, rationalizing, recognizing, repaid, repurchased, request, responsibility, Retirement, Rule, Scop, sentence, Seprafilm, serving, settlement, sharing, short, Silverman, skin, specialty, spread, strain, substantial, successfully, System, thereunder, thousand, Topic, Transderm, transferred, travel, treatment, updating, vaccine, Varma, vested, workforce, Zosyn

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated BAX transcripts

BAX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350,

as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

James K. Saccaro, as Executive Vice President and Chief Financial Officer of Baxter International Inc. (the “Company”), certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ James K. Saccaro
James K. Saccaro
Executive Vice President and Chief Financial Officer

April 27, 2023